Article
DCGI approves for Bharat Biotech to conduct intranasal booster dose trials
Rating:
0.0
Views:
62
Likes:
1
Library:
1
DCGI approves for Bharat Biotech to conduct intranasal booster dose trials - The DGCI also approved the market sale of Bharat Biotech's Covaxin and Serum Institute of India's Covishield
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value